Renovaro Biosciences (RENB) Company Overview

Profile

Full Name:

Renovaro Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 7, 2018

Indexes:

Not included

Description:

RENB (Renovaro Biosciences) focuses on developing innovative therapies using advanced biotechnology. The company aims to improve health outcomes by creating treatments for various diseases, particularly in regenerative medicine. Their research combines science and technology to enhance patient care and promote healing.

Events Calendar

Earnings

Next earnings date:

May 15, 2025

Recent quarterly earnings:

Feb 19, 2025

Recent annual earnings:

Sep 23, 2020
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Renovaro Biosciences?
  • Does Renovaro Biosciences pay dividends?
  • What sector is Renovaro Biosciences in?
  • What industry is Renovaro Biosciences in?
  • What country is Renovaro Biosciences based in?
  • When did Renovaro Biosciences go public?
  • Is Renovaro Biosciences in the S&P 500?
  • Is Renovaro Biosciences in the NASDAQ 100?
  • Is Renovaro Biosciences in the Dow Jones?
  • When was Renovaro Biosciences's last earnings report?
  • When does Renovaro Biosciences report earnings?

What is the ticker symbol for Renovaro Biosciences?

The ticker symbol for Renovaro Biosciences is NASDAQ:RENB

Does Renovaro Biosciences pay dividends?

No, Renovaro Biosciences does not pay dividends

What sector is Renovaro Biosciences in?

Renovaro Biosciences is in the Healthcare sector

What industry is Renovaro Biosciences in?

Renovaro Biosciences is in the Biotechnology industry

What country is Renovaro Biosciences based in?

Renovaro Biosciences is headquartered in United States

When did Renovaro Biosciences go public?

Renovaro Biosciences's initial public offering (IPO) was on February 7, 2018

Is Renovaro Biosciences in the S&P 500?

No, Renovaro Biosciences is not included in the S&P 500 index

Is Renovaro Biosciences in the NASDAQ 100?

No, Renovaro Biosciences is not included in the NASDAQ 100 index

Is Renovaro Biosciences in the Dow Jones?

No, Renovaro Biosciences is not included in the Dow Jones index

When was Renovaro Biosciences's last earnings report?

Renovaro Biosciences's most recent earnings report was on Feb 19, 2025

When does Renovaro Biosciences report earnings?

The next expected earnings date for Renovaro Biosciences is May 15, 2025